First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications
Top Cited Papers
Open Access
- 1 October 2000
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 107 (10) , 1265-1270
- https://doi.org/10.1111/j.1471-0528.2000.tb11618.x
Abstract
Objective To examine the value of first trimester maternal serum free β human chorionic gonadotrophin (β hCG) and pregnancy associated plasma protein A (PAPP‐A) as predictors of pregnancy complications.Design Screening study.Setting Antenatal clinics.Population Singleton pregnancies at 10–14 weeks of gestation.Methods Maternal serum free β hCG and PAPP‐A were measured at 10–14 weeks of gestation in 5584 singleton pregnancies. In the 5297 (94.9%) pregnancies with complete follow up free β hCG and PAPP‐A were compared between those with normal outcome and those resulting in miscarriage, spontaneous preterm delivery, pregnancy induced hypertension or fetal growth restriction and in those with pre‐existing or gestational diabetes.Results Maternal serum PAPP‐A increased and β hCG decreased with gestation. The multiple of median maternal serum PAPP‐A was significantly lower in those pregnancies resulting in miscarriage, pregnancy induced hypertension, growth restriction and in those with pre‐existing or gestational diabetes mellitus, but not in those complicated by spontaneous preterm delivery. The level was < 10th centile of the reference range in about 20% of the pregnancies that subsequently resulted in miscarriage or developed pregnancy induced hypertension or growth restriction, and in 27% of those that developed gestational diabetes. Maternal serum free β hCG was < 10th centile of the reference range in about 15% of the pregnancies that subsequently resulted in miscarriage or developed pregnancy induced hypertension or growth restriction, and in 20% of those that developed gestational diabetes.Conclusion Low maternal serum PAPP‐A or β hCG at 10–14 weeks of gestation are associated with subsequent development of pregnancy complications.Keywords
This publication has 23 references indexed in Scilit:
- Screening for triploidy by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationPrenatal Diagnosis, 2000
- Screening for trisomy 13 by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationPrenatal Diagnosis, 2000
- Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1999
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Serum levels of human placental lactogen, pregnancy‐associated plasma protein A and endometrial secretory protein PP14 in first trimester of diabetic pregnancyActa Obstetricia et Gynecologica Scandinavica, 1998
- Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin‐dependent diabetes: implications for screening for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- New birthweight and head circumference centiles for gestational ages 24 to 42 weeksEarly Human Development, 1987
- Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infantsBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Does ultrasound examination render biochemical tests obsolete in the prediction of early pregnancy failure?BJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Beta‐human chorionic gonadotrophin levels before and after the development of pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1984